Syracuse Scientific releases Fluorecord

Article

Syracuse Scientific of Cicero, NY, has received Food and DrugAdministration 510(k) clearance to market its Fluorecord digitalspot system for radiography/fluoroscopy units. Fluorecord is aTV-camera-based system and comes in 525- and 1000-line models.The

Syracuse Scientific of Cicero, NY, has received Food and DrugAdministration 510(k) clearance to market its Fluorecord digitalspot system for radiography/fluoroscopy units. Fluorecord is aTV-camera-based system and comes in 525- and 1000-line models.The system is designed to work with all major brands of R/F equipmentand will be marketed through dealers and distributors.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
CT Study: Modified Lung-RADS Model Offers Enhanced Prognostic Assessment of Pure Ground-Glass Nodules

CT Study: Modified Lung-RADS Model Offers Enhanced Prognostic Assessment of Pure Ground-Glass Nodules

Jeff Hall
March 26th 2025
Article

The cLung-RADS v2022 model offered a greater than 16 percent increase in the AUC in comparison to Lung-RADS 1.0 and Lung-RADS v2022 systems for predicting the invasiveness of pure ground-glass nodules.

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

Jeff Hall
March 18th 2025
Podcast

In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.

FDA Clears Gleamer’s ChestView AI Software for CXR

FDA Clears Gleamer’s ChestView AI Software for CXR

Jeff Hall
March 25th 2025
Article

Adjunctive use of the AI-powered software led to an average 38.6 percent increase in the detection of pneumothorax by general radiologists, according to a 2023 study.

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

The Reading Room Podcast: Emerging Concepts in Breast Cancer Screening and Health Equity Implications, Part 3

Jeff Hall
September 1st 2023
Podcast

In the third episode of a three-part podcast, Anand Narayan, M.D., Ph.D., and Amy Patel, M.D., discuss the challenges of expanded breast cancer screening amid a backdrop of radiologist shortages and ever-increasing volume on radiology worklists.

Could Microultrasonography-Guided Biopsy be an Alternative to MRI for PCa Detection in Biopsy-Naïve Men?

Could Microultrasonography-Guided Biopsy be an Alternative to MRI for PCa Detection in Biopsy-Naïve Men?

Jeff Hall
March 24th 2025
Article

Microultrasonography-guided biopsy offered comparable detection as MRI/conventional ultrasound-guided biopsy in detection of Gleason grade group 2 or higher prostate cancer, according to a new international multicenter study.

Keys to Overcoming Initial Inertia at the Radiology Workstation

Keys to Overcoming Initial Inertia at the Radiology Workstation

Eric Postal, MD
March 24th 2025
Article

Certain cases and disciplines can facilitate consistent momentum during the course of the day.

© 2025 MJH Life Sciences

All rights reserved.